superDimension is a privately-held medical device company that develops and markets minimally-invasive pulmonology devices that enable the diagnosis and potentially the treatment of distal lung disease. The company’s i·LogicTM System, includes both capital equipment and disposables, addressing a total available market of more than 8 million patients. Driven by a mission, “To be the world leader in the diagnosis and treatment of distal lung disease,” superDimension is focused on extending the capabilities of traditional bronchoscopy tools to help diagnose previously inaccessible lung lesions at an earlier stage when they may be easier to treat.
In March 2012 Covidien announced a definitive agreement to acquire superDimension, Ltd. for approximately $300 million, with future earn out payments possible. The transaction was completed in the second calendar quarter of 2012.